Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis

Clinical trial NCT06360861 · COMPLETED

Trial details

NCT number: NCT06360861
Sponsor: Tehran University of Medical Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis Secondary-Progressive Multiple Sclerosis Mesenchymal Stem Cells

Start date: 2019-07-23
Primary completion: 2024-03-04
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.